If your loved one with Alzheimer's disease is on one of the new treatment drugs, or you have been weighing whether to try them, the headlines from this spring may have stopped you cold. A major review from one of the most respected research organizations in the world concluded these drugs show no meaningful benefit. Researchers immediately fired back. And you are in the middle of all of it, as a caregiver trying to make real decisions for a real person.
Your confusion is completely warranted. This is not a simple story. One headline says breakthrough. The next says it does nothing. But the full picture is more complicated than either side is telling you.
In this episode I walk you through what the Cochrane review actually found, why experts are so divided on it, and the three questions you can bring to your loved one's neurologist to make a more informed decision for your specific family.
Cochrane Collaboration Review (Full Study): https://www.cochrane.org/about-us/news/anti-amyloid-alzheimers-drugs-show-no-clinically-meaningful-effect
Get free weekly tools and tips in my newsletter, The Dementia Dose: https://tinyurl.com/dementiadose-podcast
Join the Care Collective: https://tinyurl.com/podcast-cc
⏱ CHAPTERS
0:00 - The headlines that stopped caregivers
1:46 - Who these drugs are actually designed for
2:56 - What the Cochrane review found
5:26 - Why researchers are pushing back
7:50 - 3 questions to ask your loved one's doctor
#dementia #dementiacaregiver #alzheimers #caregiving #alzheimersresearch
---
Hi, I'm Dr. Natali Edmonds, a board-certified geropsychologist specializing in dementia care. Whether your loved one has Alzheimer's, frontotemporal, Lewy body, vascular, or mixed dementia, we believe that to create a dementia-friendly world, we must first create a caregiver-friendly world.
This content is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for medical guidance.
